This document lists 11 references used in a paper about lung cancer:
1. It includes references from the Indonesian Lung Doctors Association and journals on lung cancer diagnosis and treatment in Indonesia.
2. References also discuss gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR genes, as well as national clinical guidelines from Scotland.
3. Additional references cover pathology textbooks, reports from the National Collaborating Centre for Acute Care in the UK, articles on superior vena cava syndrome, and the National Comprehensive Cancer Network practice guidelines.
This document lists 11 references used in a paper about lung cancer:
1. It includes references from the Indonesian Lung Doctors Association and journals on lung cancer diagnosis and treatment in Indonesia.
2. References also discuss gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR genes, as well as national clinical guidelines from Scotland.
3. Additional references cover pathology textbooks, reports from the National Collaborating Centre for Acute Care in the UK, articles on superior vena cava syndrome, and the National Comprehensive Cancer Network practice guidelines.
This document lists 11 references used in a paper about lung cancer:
1. It includes references from the Indonesian Lung Doctors Association and journals on lung cancer diagnosis and treatment in Indonesia.
2. References also discuss gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR genes, as well as national clinical guidelines from Scotland.
3. Additional references cover pathology textbooks, reports from the National Collaborating Centre for Acute Care in the UK, articles on superior vena cava syndrome, and the National Comprehensive Cancer Network practice guidelines.
This document lists 11 references used in a paper about lung cancer:
1. It includes references from the Indonesian Lung Doctors Association and journals on lung cancer diagnosis and treatment in Indonesia.
2. References also discuss gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR genes, as well as national clinical guidelines from Scotland.
3. Additional references cover pathology textbooks, reports from the National Collaborating Centre for Acute Care in the UK, articles on superior vena cava syndrome, and the National Comprehensive Cancer Network practice guidelines.
1. Perhimpunan Dokter Paru Indonesia. 2003. Kanker Paru dalam Pedoman
Diagnosis dan Penatalaksaan di Indonesia. 2. Bakhtiar, Arief dan Soeprijanto, Bambang. 2006. Kanker Paru dan Penatalaksanaannya. Jurnal Kedokteran Syiah Kuala Vol. 6 3. Makoto et al. 2010. Gefitinib or Chemotherapy for NonSmall-Cell Lung Cancer with Mutated EGFR. N Engl J Med 362 4. Scottish Intercollegiate Guidelines network. 2005. Management of patients with lung cancer: A national clinical guidelines. Eidenburg: SIGN. 5. Jusuf A, Harryanto A, Syahruddin E, dkk. 2005. Kanker paru jenis karsinoma bukan sel kecil : Pedoman nasional untuk diagnosis dan penatalaksanaan di Indonesia. Jakarta : PDPI dan POI. 6. Price S.A, Wilson L.M. 1995. Patofisiologi. Jakarta: Penerbit Buku Kedokteran EGC. 7. National Collaborating Center for Acute Care. 2005. Lung cancer: The diagnosis and treatment of lung cancer. London: Clinical Effectiveness Unit. 8. Division of Thoracic Oncology. 2006. Focus on Lung Cancer. 9. Wilson, L.D., Detterbeck, F.C., and Yahalom, J. 2007. Superior Vena Cava Syndrome with Malignant Case. The New England Journal of Medicine 356 10. Suyono, Slamet. 2001, Buku Ajar Ilmu Penyakit Dalam, Jilid II. Jakarta: Balai Penerbit FKUI. 11. National Comprehensive Cancer Network (NCCN). 2002. Practice Guidelines in Oncology Non-small Cell Lung Cancer.